Ask Warren

Keeps Biopharma

256940 · KOSDAQ · ₩256940 · 킵스파마

₩5,310▼ ₩200 (3.63%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩75B₩59B₩45B₩41B₩43B₩41B₩33B₩32B
Cost of sales₩66B₩49B₩34B₩32B₩35B₩32B₩31B₩28B
Gross profit₩9.1B₩10B₩11B₩9.4B₩8.1B₩9B₩2.3B₩4B
Operating income−₩2.4B−₩664M₩1B₩1.4B−₩976M₩89M−₩1.3B₩1B
Net income−₩9.2B₩5.7B−₩9.2B−₩446M₩718M−₩1.4B₩1.4B−₩1.4B
Net income to shareholders−₩8.8B₩5.7B−₩8.8B−₩451M₩1.2B−₩1.7B₩963M−₩1.7B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩234B₩244B₩234B₩214B₩211B₩181B₩165B₩144B
Current assets₩107B₩117B₩102B₩111B₩110B₩82B₩71B₩64B
Cash and equivalents₩12B₩22B₩22B₩33B₩39B₩21B₩19B₩28B
Total liabilities₩154B₩159B₩152B₩124B₩122B₩111B₩102B₩82B
Current liabilities₩101B₩92B₩89B₩72B₩72B₩84B₩85B₩49B
Borrowings₩82B₩94B₩92B₩71B₩69B₩62B₩55B₩41B
Total equity₩80B₩85B₩82B₩90B₩89B₩70B₩63B₩62B
Shareholders' equity₩63B₩67B₩62B₩76B₩74B₩55B₩50B₩50B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations−₩4.6B₩245M−₩4B−₩3.2B−₩3.1B−₩4.6B₩1.8B₩1.4B
Capital spending₩1.7B₩1.5B₩27B₩2B₩2.2B₩731M₩1.5B₩3.9B
Free cash flow−₩6.4B−₩1.2B−₩31B−₩5.2B−₩5.3B−₩5.4B₩255M−₩2.4B

Consolidated where available. Amounts in won.

Also known as: Keeps Biopharma / 킵스파마 / 256940 / KRX:256940

Source: KRX statistical information